Much like camera settings—filters, flashes and focus—affect what we notice in a final photo, the way scientists measure ...
Secret Life of Mom on MSN
Science reveals this is what happens to your brain during prayer
Research shows the brain during prayer activates social cognition networks, reduces stress, and builds measurable neural ...
Over 70 million people in the U.S. are impacted by hearing loss, and age-related hearing loss is the second most common ...
ADHD patients deserved a more consistent, safe and manageable medication experience. Imagining a better way forward, they ...
KANSAS CITY, Kan., June 16, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
FDA feedback centered on CMC documentation and quality/manufacturing controls, a common first-cycle barrier that typically does not necessitate additional efficacy or safety trials. Pediatric ...
Cingulate said the Food and Drug Administration flagged certain chemistry, manufacturing and controls requests in response to its application for a drug treating ADHD. The Kansas City, Kan., ...
June 2 (Reuters) - Drug developer Cingulate (CING.O), opens new tab said on Tuesday the U.S. Food and Drug Administration declined to approve its treatment for attention deficit hyperactivity ...
After submitting its timed-release version of a decades-old ADHD drug to the FDA nearly a year ago, Kansas City's Cingulate has suffered a setback in its bid to commercialize its first product. But ...
Cingulate Inc. (NASDAQ:CING) is one of the best NASDAQ growth stocks to buy and hold forever. On March 18, Cingulate reported its financial results for Q4 and the full year 2025, highlighting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results